Back to top
more

Tilray Brands (TLRY)

(Delayed Data from NSDQ)

$1.63 USD

1.63
24,936,601

+0.04 (2.52%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $1.62 -0.01 (-0.61%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Consumer Products - Staples

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed at $81.91 in the latest trading session, marking a +1.76% move from the prior day.

Sanghamitra Saha headshot

What Makes Marijuana ETF the Best Performer in January?

by Sanghamitra Saha

These are the factors that led marijuana ETF to see a strong start to 2019.

Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray, Inc. (TLRY) closed at $71.74, marking a -1.46% move from the previous day.

Ryan McQueeney headshot

Earnings from Netflix & Big Banks, & This Week in Cannabis Deals

by Ryan McQueeney

Ryan McQueeney and Maddy Johnson discuss earnings results from Netflix and the big U.S. banks. The hosts also remember the legacy of Jack Bogle and chat about several new cannabis industry deals.

Options Traders Expect Huge Moves in Tilray (TLRY) Stock

by Zacks Equity Research

Tilray (TLRY) needs investors to pay close attention to the stock based on moves in the options market lately.

Is the Options Market Predicting a Spike in Tilray (TLRY) Stock?

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Zacks Investment Ideas feature highlights: Tilray, Canopy and Cronos

by Zacks Equity Research

Zacks Investment Ideas feature highlights: Tilray, Canopy and Cronos

Intrexon Signs Licensing Agreement with Next Green Wave

by Zacks Equity Research

Intrexon (XON) partners with Next Green Wave Holdings to utilize Intrexon's Botticelli next-generation plant propagation platform.

Ryan McQueeney headshot

A Week of Cannabis Investing Deals & Earnings Reports from GS, BAC, UAL

by Ryan McQueeney

Ryan McQueeney covers the latest Brexit news and Snap's executive exodus. He also recaps earnings results from Goldman Sachs, Bank of America, and United Air Lines. Later, he discusses a busy week for deals in the cannabis industry.

Tilray Teams Up With Authentic Brands, Stock Down on Sell-Off

by Zacks Equity Research

Tilray (TLRY) signs a marketing agreement with Authentic Brands Group to sell consumer cannabis products.

Ryan McQueeney headshot

Why Did Tilray (TLRY) Stock Drop Sharply Today?

by Ryan McQueeney

Shares of Tilray (TLRY) fell more than 17% on Tuesday after its post-IPO lockup period expired, allowing early investors in the Canadian marijuana company to cash out of their positions for the first time.

David Borun headshot

Tilray's Tuesday Slide Due to IPO Lockup Expiration

by David Borun

Tilray's biggest shareholder resolves to stay long for the foreseeable future

Tilray Shares Rally as Investor Plans Not to Sell Shares

by Zacks Equity Research

Tilray (TLRY) gains after Privateer Holdings decides not to sell shares in the first half of 2019.

Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Tilray, Inc. (TLRY) closed the most recent trading day at $80.40, moving +0.88% from the previous trading session.

Zacks Market Edge Highlights: Tilray, Constellation Brands, Altria and GW Pharmaceuticals

by Zacks Equity Research

Zacks Market Edge Highlights: Tilray, Constellation Brands, Altria and GW Pharmaceuticals

Tracey Ryniec headshot

Pot Stocks in 2019: A Year of Transition

by Tracey Ryniec

In 2018, investors pinned their pot stock hopes on Canadian legalization but in 2019 the game has changed. Who will emerge as the winners?

Softness in Beer Hurt Alcohol Stocks, Can Cannabis Change Fate?

by Zacks Equity Research

The alcohol space continues its struggles against soft beer sales and higher costs. Meanwhile, cannabis-infused drinks are gaining popularity.

Tilray Gains More Than 200%: Is There More Scope for Growth?

by Zacks Equity Research

Tilray (TLRY) gains more than 200% in the past six months. Strategic deals should propel further growth.

Tilray, Inc. (TLRY) Stock Moves -0.65%: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray, Inc. (TLRY) closed at $70, marking a -0.65% move from the previous day.

Does AB InBev (BUD) Stock Have Potential to Rebound in 2019?

by Zacks Equity Research

AB InBev (BUD) suffers on account of softness in the beer industry, particularly in the United States, which is hurting its sales. However, its recent venture in cannabis space is encouraging.

Nitish Marwah headshot

5 Best-Performing IPOs of 2018

by Nitish Marwah

Strong economic fundamentals and increased foreign investment have led to such a high number of companies going public.

Company News For Dec 21, 2018

by Zacks Equity Research

Companies In The News Are: WBA,BB,CCL,TLRY,BUD

Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

AB InBev (BUD) Enters Booming Cannabis Realm With Tilray Deal

by Zacks Equity Research

AB InBev (BUD) announces partnership with the leading marijuana producer, Tilray.

Tilray Stock Up on Medical Cannabis Collaboration With Sandoz

by Zacks Equity Research

Tilray (TLRY) expands its previous collaboration deal with Sandoz, a generic arm of Novartis, to supply medical cannabis globally using the latter's supply chain.